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  EVIDENCE-BASED ANSWER 
For children, antibiotics do not appear to improve short-term (3-6 weeks) or long-term (3 months) outcomes of 
chronic rhinosinusitis (strength of recommendation [SOR]: A, randomized controlled trials). No adequate 
placebo-controlled trials have been performed in adults. Two consensus statements report that 10 to 21 days 
of antibiotics active against organisms producing beta-lactamase might be beneficial in some cases (SOR: C). 
  EVIDENCE SUMMARY 
The American Academy of Otolargynology-Head and Neck Surgery defines chronic rhinosinusitis as the 
persistence of 2 major or 1 major and 2 minor criteria lasting at least 12 weeks ( Table ).1 The other categories 
of rhinosinusitis are acute (symptoms lasting <3 weeks) and subacute (symptoms lasting 3-12 weeks). 
Two placebo-controlled trials have evaluated antibiotic treatment of chronic rhinosinusitis in children. In 1 
study, 141 children with chronic rhinosinusitis were randomly assigned to 1 of 4 treatment arms: saline nose 
drops; xylometazoline (Otrivin) drops with oral amoxicillin 3 times daily; surgical drainage; or surgical drainage, 
amoxicillin 3 times daily and xylometazoline drops.2 Outcomes were resolution of purulent rhinitis, no purulent 
drainage on exam, and no abnormalities of maxillary sinus on x-ray. The absence of all 3 findings constituted 
cure. At 6 weeks there was a non-statistically significant higher resolution in the fourth group, but by 26 weeks 
the groups were indistinguishable. At 6 weeks, 53%, 50%, 55%, and 79% of each group, respectively, were 
cured. These results increased to 69%, 74%, 69%, and 64% at 26 weeks. 
Another study randomized 79 children with chronic sinusitis to treatment with cefaclor vs placebo following 
antral washout.3 Measured outcomes were similar to those in the prior study. At 6 weeks, 12.3% more patients 
in the antibiotic group achieved cure than the placebo group (64.8% vs 52.5%), but this difference was not 
statistically significant (P=.28). At 12 weeks, no differences in improvement were seen between the 2 groups 
(89% vs 89.5%) 
No studies (since 1966) have evaluated antibiotic use compared with placebo in adults. We did not review the 
numerous studies comparing different antibiotics without placebo. 
  RECOMMENDATIONS FROM OTHERS 
The American Academy of Otolaryngology-Head and Neck Surgery, in conjunction with the American Academy 
of Rhinology and the American 
Academy of Otolaryngic Allergy, state that the use of antibiotics active against beta-lactamase producing 
organisms might be beneficial in some cases.3 A consensus statement from a panel convened in Belgium in 
1996 stated antibiotics should be given for 5 to 7 days with repeat treatments if the child does not respond 
initially.5 
 
TABLE 2 
Diagnostic criteria for rhinosinusitis 
Major criteria 
Facial pain/pressure* 
Facial congestion/fullness 
Nasal obstruction/blockage 
Nasal discharge/purulence/discolored drainage 
Hyposmia/anosmia 
Purulence in nasal cavity on examination 
Fever (acute only)* 
Minor criteria 
Headache 
Fever (all nonacute) 
Halitosis 
Fatigue 
Dental pain 
Cough 
Ear pain/pressure/fullness 
*Symptom alone does not constitute a major sign in the absence of another major 
nasal symptom. Adapted from Lanza DC, 1997.1 
CLINICAL COMMENTARY 
Antibiotics provide only short-term relief, not long-
term answers 
 
William  A.  Hensel,  MD 
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For chronic sinusitis, I start by emphasizing nonantibiotic treatments, such as 
decongestants, nasal steroids, antihistamines, smoking cessation, and avoidance of 
passive smoke, allergens, and other irritants. With education and experience, patients 
realize that antibiotics provide only short-term relief, not long-term answers. Having 
learned this, patients can better participate in antibiotic treatment decisions. Most are able 
to weigh the short-term, symptomatic benefits against potential medication side effects 
and the cost. I believe that 2 or 3 courses of antibiotics per year are not excessive, but I 
try not to exceed that limit. 
Finally, I don’t always choose a beta-lactamase-resistant antibiotic. Given that antibiotics 
do not alter the long-term prognosis, I worry less about resistance and more about 
minimizing cost and side-effect potential. Therefore, I occasionally treat with amoxicillin or 
Pen Vee K. Patients seem to appreciate my flexibility and collaborative approach to 
decision-making. 
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